50
Participants
Start Date
November 6, 2019
Primary Completion Date
April 12, 2024
Study Completion Date
April 12, 2024
asfotase alfa
This is an observational study and no intervention will be administered. All participants will be treated by their physician in accordance with standard of care. All medications are commercially available and will be used as directed by the treating physician.
Xcenda, LLC, Palm Harbor
Lead Sponsor
Xcenda, LLC
UNKNOWN
Alexion Pharmaceuticals, Inc.
INDUSTRY